GlobeNewswire

Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference
04/11/2026
BERKELEY HEIGHTS, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or “the Company”), a fully integrated, commercial-stage biopharmaceutical company, today announced [...]
Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
04/11/2026
CORAL GABLES, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central [...]
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
04/11/2026
In-licensing of ex-China rights to two potentially best-in-class compounds (NXP100 and NXP200) from Haisco Pharmaceutical Group transformed Nuvectis into a late-stage clinical development company. The Company’s lead [...]
BioCryst Reports Third Quarter 2026 Financial Results
04/11/2026
— Total net revenue of $180.3 million and ORLADEYO ® net revenue of $174.8 million — — Operating profit of $53.3 million and Non-GAAP operating profit of $86.5 million — — Maintained Full Year 2026 ORLADEYO revenue [...]
Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
04/11/2026
Additional analyses from the Phase 2a induction period for OD-001 further strengthen clinical proof of concept in ulcerative colitis Completed IND-enabling studies for OD-002, a first-in-class oral SLC15A4 inhibitor $ [...]
Biora Therapeutics Receives Approval for First-in-Human Trial of BioJet™ Oral Biologic Delivery Capsule
04/11/2026
Company remains on track to initiate clinical study evaluating oral, needle-free delivery of adalimumab in December 2026 with data expected in early 2027 SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Biora Therapeutics, [...]
Verano Expands Florida Retail Footprint to 87 Locations with Grand Opening of MÜV Fernandina Beach, the Company’s 164th Dispensary Nationwide
04/11/2026
Situated on the scenic Amelia Island in Florida’s Nassau County, MÜV Fernandina Beach is located at 1940 S 8 th Street, a busy thoroughfare that averages a daily traffic count of 20,100 vehicles daily 1 MÜV Fernandina [...]
Ocugen Provides Business Update with Third Quarter 2026 Financial Results
04/11/2026
Conference Call and Webcast Today at 8:30 a.m. ET Received Provisional Approval and Priority Designation for OCU400 in The Bahamas Executed agreement with local partner Global Alliance for Regenerative Medicine (GARM) [...]
Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)
04/11/2026
Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an additional broad therapeutic opportunity for SER-155 Seres expects to [...]
Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update
04/11/2026
Positive topline results from Phase 2 trial of RAP-219 in bipolar mania; initiation of two Phase 3 trials in bipolar mania expected in 2H 2027 Data from the Phase 2 FOS open-label long-term safety trial expected in 4Q [...]
BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting
04/11/2026
Clinical data demonstrate target engagement and support the potential for BH-30236 to address therapeutic resistance in relapsed/refractory AML and HR-MDS SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- BlossomHill [...]
Biodesix to Participate in Upcoming Investor Conferences
04/11/2026
LOUISVILLE, Colo., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present at two upcoming [...]
Nxera Pharma Revises Consolidated Financial Forecast for the Year Ending 31 December 2026
04/11/2026
Tokyo, Japan and Cambridge, UK, 4 November 202 6 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) today announces that it has revised its consolidated financial forecast for the year ending 31 December 2026, [...]
Nxera Pharma Enters into Global License Agreement with AbbVie for NXE0033744, a Novel EP4 Receptor Agonist for Inflammatory Bowel Disease
04/11/2026
Nxera to receive US$100 million upfront and be eligible for up to US$1.37 billion in development and commercial milestone payments, plus tiered royalties. NXE0033744, an investigational oral EP4 receptor agonist [...]
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies
04/11/2026
Partnership provides opportunities to further expand Boehringer Ingelheim’s portfolio of antibody-drug conjugates (ADCs) and T-cell engagers (TcEs) Agreement reinforces Boehringer Ingelheim’s long-term commitment to [...]
Novo raises full-year outlook on continued GLP-1 momentum, with third-quarter adjusted operating profit increasing 27% at CER to DKK 31,720 million
04/11/2026
4 November - Financial report for the period 1 January 2026 to 30 September 2026 Financial performance Q3 2026 adjusted and reported sales increased by 4% at CER, driven by continued GLP-1 volume growth across the US [...]
German hospital introduces miscarriage care device
04/11/2026
New device offers dignified support for early pregnancy loss HAMBURG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- A HOSPITAL in northern Germany has become the first in mainland Europe to offer an innovative medical device [...]
Breakthrough Therapy Designation granted by the FDA for daridorexant in pediatric insomnia disorder
04/11/2026
The FDA recognizes through this designation both the clinical evidence supporting daridorexant and the significant unmet medical need in pediatric insomnia, where no FDA-approved pharmacological treatments are currently [...]
Eliminating Static Without Electricity - MEC Industries Introduces the Powerless ECO Ionizer
04/11/2026
Powerless ECO Ionizer Eliminates Static Without Electricity SEOUL, South Korea, Nov. 03, 2026 (GLOBE NEWSWIRE) -- MEC Industries introduces the Powerless ECO Ionizer , a static-control device that operates without an [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum